AGP Picks
View all

Niue Health Report
Provided by AGP

Niue Health Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Niue Health Report.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on May 27, 2026

New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026
May 27, 2026

New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026

Indeterminate GlobeNewswire
HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
May 27, 2026

HCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen

Indeterminate GlobeNewswire
Medline announces participation in upcoming investor conferences
May 27, 2026

Medline announces participation in upcoming investor conferences

Indeterminate GlobeNewswire
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
May 27, 2026

BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9

Indeterminate GlobeNewswire
Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics
May 27, 2026

Reprogram Biosciences Closes Seed Financing to Advance Tumor Cell Reprogramming Therapeutics

Indeterminate GlobeNewswire
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
May 27, 2026

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions
May 27, 2026

MitoRx Therapeutics to present new preclinical data on MTRX31, its novel mitochondrial-targeted small molecule at the American Diabetes Association’s 2026 Scientific Sessions

Indeterminate GlobeNewswire
L’Association canadienne de dermatologie, en partenariat avec Mélanome Canada, offrira des dépistages gratuits du cancer de la peau sur la Colline du Parlement
May 27, 2026

L’Association canadienne de dermatologie, en partenariat avec Mélanome Canada, offrira des dépistages gratuits du cancer de la peau sur la Colline du Parlement

Indeterminate GlobeNewswire
Satellos to Participate in Upcoming Investor Conferences
May 27, 2026

Satellos to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference
May 27, 2026

Harrow to Present at William Blair’s 46th Annual Growth Stock Conference

Indeterminate GlobeNewswire
X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026

X4 Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
May 27, 2026

NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System

Indeterminate GlobeNewswire
Sharps Technology Becomes SkyAI, Inc. with New Ticker Symbol “SKYA”; Establishing Category-defining Agentic Finance Platform Serving Global South
May 27, 2026

Sharps Technology Becomes SkyAI, Inc. with New Ticker Symbol “SKYA”; Establishing Category-defining Agentic Finance Platform Serving Global South

Indeterminate GlobeNewswire
MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update
May 27, 2026

MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026

ANI Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
LifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children
May 27, 2026

LifeArc announces partnership with Elpida Therapeutics to accelerate gene therapies for ultra-rare diseases in children

Indeterminate GlobeNewswire
Bonito Biosciences and DaltonTx Announce AI-Driven Collaboration to Advance Precision Delivery for Oligotherapeutics
May 27, 2026

Bonito Biosciences and DaltonTx Announce AI-Driven Collaboration to Advance Precision Delivery for Oligotherapeutics

Indeterminate GlobeNewswire
Aligos Therapeutics Presents Positive Data at the EASL Congress 2026
May 27, 2026

Aligos Therapeutics Presents Positive Data at the EASL Congress 2026

Indeterminate GlobeNewswire
Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships
May 27, 2026

Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships

Indeterminate GlobeNewswire
New study reveals promising new way to find serious liver disease earlier
May 27, 2026

New study reveals promising new way to find serious liver disease earlier

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Niue Health Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.